AVDL vs. VASGX
Compare and contrast key facts about Avadel Pharmaceuticals plc (AVDL) and Vanguard LifeStrategy Growth Fund (VASGX).
VASGX is managed by Vanguard. It was launched on Sep 30, 1994.
Performance
AVDL vs. VASGX - Performance Comparison
Loading graphics...
AVDL vs. VASGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AVDL Avadel Pharmaceuticals plc | 0.42% | 105.04% | -25.57% | 97.21% | -11.39% | 20.96% | -11.52% | 192.64% | -68.54% | -21.08% |
VASGX Vanguard LifeStrategy Growth Fund | -0.41% | 19.65% | 12.95% | 18.76% | -17.21% | 14.35% | 15.45% | 23.14% | -6.89% | 19.21% |
Returns By Period
AVDL
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
VASGX
- 1D
- 0.90%
- 1M
- -2.60%
- YTD
- -0.41%
- 6M
- 1.82%
- 1Y
- 18.59%
- 3Y*
- 14.59%
- 5Y*
- 7.62%
- 10Y*
- 9.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVDL vs. VASGX — Risk / Return Rank
AVDL
VASGX
AVDL vs. VASGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Avadel Pharmaceuticals plc (AVDL) and Vanguard LifeStrategy Growth Fund (VASGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| AVDL | VASGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.43 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.60 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.73 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | 0.56 | — |
Correlation
The correlation between AVDL and VASGX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AVDL vs. VASGX - Dividend Comparison
AVDL has not paid dividends to shareholders, while VASGX's dividend yield for the trailing twelve months is around 4.11%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVDL Avadel Pharmaceuticals plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VASGX Vanguard LifeStrategy Growth Fund | 4.11% | 4.09% | 6.15% | 3.00% | 2.10% | 3.54% | 3.54% | 2.34% | 4.36% | 2.13% | 2.23% | 4.54% |
Drawdowns
AVDL vs. VASGX - Drawdown Comparison
Loading graphics...
Drawdown Indicators
| AVDL | VASGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -51.16% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -8.17% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.53% | — |
Current DrawdownCurrent decline from peak | — | -5.16% | — |
Average DrawdownAverage peak-to-trough decline | — | -7.29% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.13% | — |
Volatility
AVDL vs. VASGX - Volatility Comparison
Loading graphics...
Volatility by Period
| AVDL | VASGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 4.98% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 8.11% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 13.40% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 12.70% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 13.44% | — |